COMBINATION OF TAXOL WITH CARBOPLATIN IN THE TREATMENT OF PATIENTS WITH STAGES IIB-IV OVARIAN CANCER (FIRST MULTI-CENTER EXPERIENCE IN RUSSIA)
Taking into account the fact that the treatment of advanced ovarian cancer includes cytoreductive surgery and chemotherapy, it is important to take advantage of contemporary highly effective agents. In 2003 the Regional program for optimization of ovarian cancer treatment in Cancer centers of Russia...
Main Authors: | Zh. A. Martinova, I. V. Poddubnaya |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2014-09-01
|
Series: | Opuholi Ženskoj Reproduktivnoj Sistemy |
Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/354 |
Similar Items
-
Cisplatin, cyclophosphamide versus taxol, carboplatin in epithelial ovarian carcinoma: a clinical trial
by: Modarres M, et al.
Published: (2007-05-01) -
Up-regulation of GSTT1 in serous ovarian cancer associated with resistance to TAXOL / carboplatin
by: Jing Zhang, et al.
Published: (2021-09-01) -
Dose-dense weekly paclitaxel and carboplatin compared with conventional paclitaxel and carboplatin treatment for stage II-IV ovarian cancer patients
by: Zhenhua Du, et al.
Published: (2015-07-01) -
Survival and Side Effects of Cisplatin/Cyclophosphamide and Carboplatin/Paclitaxel Adjuvant Chemotherapy in Stage IC-IV Ovarian Cancer
by: Unedo H Markus, et al.
Published: (2015-04-01) -
Combination Therapy of Albumin-Bound Paclitaxel and Carboplatin as First Line Therapy in a Patient with Ovarian Cancer
by: K. N Srinivasan, et al.
Published: (2014-01-01)